Artec, Inc. (Bulls Board) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Artec, Inc. (Bulls Board)

ATKJ 0.00

May 17 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: donpat	7/11/2005 8:16:14 AM
	of 51

Update from Dr. Shinn OWNERSHIP OF TUBERCIN CONFIRMED BY COURT RULING Sacramento , California. July 11, 2005. Dr. Ronald Shinn, President and CEO of Artec, Inc. (ATKJ.PK) announced a Federal Court ruling declaring Shinn Capital, Inc's ownership of rights to Tubercin. Artec holds a sub-license agreement for the development and marketing of Tubercin from Shinn Capital. A copy of the complete opinion can be found on the website of Hard to Treat Diseases, Inc. ( www.htdsotc.com ), under Corporate, Legal, Memorandum; shareholders and other interested persons are encouraged to read the ruling in its entirety. “We are grateful for the time and attention that the Court gave to this matter, and obviously are pleased that the Court confirmed the ownership of Tubercin”. Artec will be updating its Disclosure Statement and financial information on www.pinksheets.com this week, and plans an announcement with respect to Artec's development and marketing plans for Tubercin later this month. artec-inc.net

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next